Contact
Listings
Educational Background
- Ph.D., Supply Chain & Operations, Carlson School of Management, University of Minnesota, 2024
- Post Graduate Programme, Management, Indian School of Business, 2013
- B.T., Mechanical Engineering, National Institute of Technology, 2008
Positions Held
- Assistant Professor of Business Administration, Business Administration, University of Illinois at Urbana-Champaign, 2024 to present
Recent Publications
- Hietlage, V., Farley, J., Shah, R., Tyagi, H., & Stenehjem, D. (2022). EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share. Value in Health. link >
- Tyagi, H., Sabharwal, M., Dixit, N., Pal, A., & Deo, S. (2020). Leveraging Providers’ Preferences to Customize Instructional Content in Information and Communications Technology- Based Training Interventions: Retrospective Analysis of a Mobile Phone-Based Intervention in India JMIR mHealth and uHealth. link >
- Deo, s., Tyagi, H., Chatterjee, C., & Molakapuri, H. (2020). Did India’s price control policy for coronary stents create unintended consequences? Social Science & Medicine. link >
- Tyagi, H. (2018). Digital Health Start-ups: The Challenge of Scale. ISBInsight.
Other Publications
Articles
- Deo, S., & Tyagi, H. (2018). Rx ICT: Digitally Disrupting Healthcare. ISBInsight.
- Powell, A., Tyagi, H., & Ludhar, J. (2018). Digitising Indian healthcare records. ISBInsight.
- Tyagi, H. (2018). Taking Off: Digital Health Start-ups in India. ISBInsight.
Conference Proceedings
- Tyagi, H., Hermosilla, M., & Shah, R. (2023). How does Transparency Impact Technological Novelty? Evidence from Large Pharmaceutical Firms. Academy of Management Proceedings. link >
Working Papers
- Tyagi, H., Hermosilla, M., & Shah, R. Does Transparency Hinder Technological Novelty? Evidence From Large Pharmaceutical Firms.
- Tyagi, H., & Shah, R. Balancing Speed-Safety Tradeoffs in the Drug Approval Process.
Teaching Interests
Operations Management
Supply Chain Management
Research Interests
Drug innovation & new product development
Drug stockouts & shortages
Drug quality Management
Pharma supply chain transparency